Sign in

CIK 0001660334

  • Non-accelerated filer
  • Smaller reporting company

Verrica Pharmaceuticals Inc.

Sign in to watch
Ticker
VRCA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463137900
Phone
+1 484-453-3300
Business address
44 WEST GAY STREET, SUITE 400, WEST CHESTER, PA
  1. 4 Open-market buy Director bought 22,921,348 shares
  2. 4 Grant or award Interim CFO acquired 54,267 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Derivatives Options or other derivatives
  7. 4 Gift Director gave 2,675,611.25 shares (gift)
  8. 4 Open-market sale CHIEF LEGAL OFFICER sold 35,713 shares at an average $2.61 ($93,091)
  9. 4 Open-market sale Chief Medical Officer sold 13,489 shares at an average $2.61 ($35,161)
  10. 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 33,702 shares at an average $2.61 ($87,849)
  11. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 29,719 shares at an average $2.61 ($77,473)
  12. 4 Open-market sale PRESIDENT AND CEO sold 34,000 shares at an average $2.61 ($88,636)
  13. 4 Open-market sale PRESIDENT AND CEO sold 32,623 shares at an average $7.06 ($230,306)
  14. 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 25,576 shares at an average $7.06 ($180,557)
  15. 4 Open-market sale Chief Medical Officer sold 18,507 shares at an average $7.06 ($130,653)
  16. 4 Open-market sale CHIEF LEGAL OFFICER sold 21,740 shares at an average $7.06 ($153,477)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 13 · 253 filings